Literature DB >> 12383639

Distribution and characterization of class 1 integrons in Salmonella enterica serotype Gallinarum biotype Gallinarum.

Hyuk Joon Kwon1, Tae Eun Kim, Sun Hee Cho, Jae Goo Seol, Bum Joon Kim, Jin Won Hyun, Kyoung Yoon Park, Sun Joong Kim, Han Sang Yoo.   

Abstract

Fowl typhoid caused by Salmonella enterica subsp. enterica serotype Gallinarum biotype Gallinarum is the most important chicken disease in Korea. Due to appearance of new or multiple antibiotics resistances in the recently isolated strains, it was difficult to control the disease using antibiotics in our country. Therefore, the prevalence and genetic contents of class 1 integrons in biotype Gallinarum isolated between 1992 and 2001 were investigated by PCR and direct sequencing, respectively. Out of 90 strains, 35 (39%) carried class 1 integrons. The 1.0, 1.6 and 2.0kbp amplicons were amplified in 32 strains (36%), 2 strains (2%) and 1 strain (1%), respectively. The 1.0, 1.6 and 2.0 kbp amplicons contained one (aadA1a), two (aadB-aadA1b) and three cassettes (dhfrXII-orfF-aadA2), respectively, providing resistances against aminoglycosides (aadA1a, aadA1b, aadB, and aadA2) and trimethoprim (dhfrXII). The integron-carrying strains of biotype Gallinarum appeared in 1996 and acquired additional cassettes in 2000. Although the resistances to ampicillin, tetracycline and chloramphenicol are unrelated to class 1 integrons, relatively high prevalence of integron in biotype Gallinarum may be a dormant threat to the chemotherapy of the disease in the near future because of potency to acquire additional antibiotics resistances.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12383639     DOI: 10.1016/s0378-1135(02)00257-2

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  7 in total

1.  Chronological study of antibiotic resistances and their relevant genes in Korean avian pathogenic Escherichia coli isolates.

Authors:  Tae-Eun Kim; Yong-Wun Jeong; Sun-Hee Cho; Sun-Joong Kim; Hyuk-Joon Kwon
Journal:  J Clin Microbiol       Date:  2007-08-08       Impact factor: 5.948

2.  Characterization of a T7-like lytic bacteriophage (phiSG-JL2) of Salmonella enterica serovar gallinarum biovar gallinarum.

Authors:  Hyuk-Joon Kwon; Sun-Hee Cho; Tae-Eun Kim; Yong-Jin Won; Jihye Jeong; Se Chang Park; Jae-Hong Kim; Han-Sang Yoo; Yong-Ho Park; Sun-Joong Kim
Journal:  Appl Environ Microbiol       Date:  2008-09-26       Impact factor: 4.792

3.  Antimicrobial resistance, class 1 integrons, and genomic island 1 in Salmonella isolates from Vietnam.

Authors:  An T T Vo; Engeline van Duijkeren; Wim Gaastra; Ad C Fluit
Journal:  PLoS One       Date:  2010-02-26       Impact factor: 3.240

4.  Multiple-drug resistance in D-tartrate-positive Salmonella enterica serovar paratyphi B isolates from poultry is mediated by class 2 integrons inserted into the bacterial chromosome.

Authors:  Angelika Miko; Karin Pries; Andreas Schroeter; Reiner Helmuth
Journal:  Antimicrob Agents Chemother       Date:  2003-11       Impact factor: 5.191

5.  The consequences of a sudden demographic change on the seroprevalence pattern, virulence genes, identification and characterisation of integron-mediated antibiotic resistance in the Salmonella enterica isolated from clinically diarrhoeic humans in Egypt.

Authors:  K M Osman; W M M Hassan; R A H Mohamed
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-18       Impact factor: 3.267

6.  Carriage of Class 1 integrons and molecular characterization of intI1 gene in multidrug-resistant Salmonella spp. isolates from broilers.

Authors:  Renu Gupta; Sneh Lata Chauhan; Sunil Kumar; Naresh Jindal; N K Mahajan; V G Joshi
Journal:  Vet World       Date:  2019-04-25

7.  Genomic comparison of diverse Salmonella serovars isolated from swine.

Authors:  Sushim K Gupta; Poonam Sharma; Elizabeth A McMillan; Charlene R Jackson; Lari M Hiott; Tiffanie Woodley; Shaheen B Humayoun; John B Barrett; Jonathan G Frye; Michael McClelland
Journal:  PLoS One       Date:  2019-11-01       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.